0001209191-20-059443.txt : 20201119
0001209191-20-059443.hdr.sgml : 20201119
20201119170018
ACCESSION NUMBER: 0001209191-20-059443
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201117
FILED AS OF DATE: 20201119
DATE AS OF CHANGE: 20201119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Somaiya Mayur Ian
CENTRAL INDEX KEY: 0001760303
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 201329456
MAIL ADDRESS:
STREET 1: TCR2 THERAPEUTICS INC.
STREET 2: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-17
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001760303
Somaiya Mayur Ian
C/O TCR2 THERAPEUTICS
100 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Common Stock
2020-11-17
4
M
0
2000
5.88
A
5139
D
Common Stock
2020-11-17
4
S
0
2000
30.00
D
3139
D
Common Stock
2020-11-17
4
S
0
1666
30.00
D
1473
D
Stock Option (Right to Buy)
5.88
2020-11-17
4
M
0
2000
0.00
D
2028-04-29
Common Stock
2000
104558
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
25% of this option shall vest and become exercisable on April 9, 2019, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Margaret Siegel as Attorney-in-Fact
2020-11-19